Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
AstraZeneca
Dow
Queensland Health
Daiichi Sankyo
UBS
US Army
Farmers Insurance
Julphar

Generated: June 21, 2018

DrugPatentWatch Database Preview

CONRAY 325 Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Conray 325, and when can generic versions of Conray 325 launch?

Conray 325 is a drug marketed by Mallinckrodt and is included in one NDA.

The generic ingredient in CONRAY 325 is iothalamate sodium. There is one drug master file entry for this compound. Additional details are available on the iothalamate sodium profile page.
Summary for CONRAY 325
Drug patent expirations by year for CONRAY 325
Synonyms for CONRAY 325
1225-20-3
2276-90-6 (Parent)
5-Acetylamino-N-methyl-2,4,6-triiodoisophthalamic acid sodium salt
AN-22363
Angio-Conray
Angio-contrix
Benzoic acid, 3-(acetylamino)-2,4,6-triiodo- 5-[(methylamino)carbonyl]-, monosodium salt
Benzoic acid, 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)-, monosodium salt
Benzoic acid, 3-(acetylamino)-2,4,6-triiodo-5-[(methylamino)carbonyl]-, monosodium salt
CAS-1225-20-3
CHEMBL1097620
Conray 300
Conray 400
Conray 400 (TN)
Conray 80
Conray-400
D02KCV
D03603
DR003422
DSSTox_CID_31457
DSSTox_GSID_57668
DSSTox_RID_97343
DTXSID1057668
EINECS 214-955-8
Iotalamate de sodium
Iotalamate de sodium [French]
Iothalamate sodium
Iothalamate sodium (injection)
Iothalamate sodium (USP)
Iothalamate Sodium [USAN]
Iothalamate sodium [USP]
Iothalamate sodium salt
Iothalamic acid sodium salt
Isophthalamic acid, 5-acetamido-2,4,6-triiodo-N-methyl-, monosodium salt
Isophthalamic acid, 5-acetamido-2,4,6-triiodo-N-methyl-, sodium salt
ISOPHTHALAMIC ACID, 5-ACETYLAMINO-N-METHYL-2,4,6-TRIIODO-, SODIUM SALT
KDN276D83N
LS-85186
Mediocontrix
Monosodium 5-acetamido-2,4,6-triiodo-N-methylisophthalamate
NCGC00253600-01
OR209625
OR209626
SCHEMBL159919
Sodium 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoate
SODIUM 3-(ACETYLAMINO)-2,4,6-TRIIODO-5-[(METHYLAMINO)CARBONYL]BENZOATE
sodium 3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoate
Sodium iotalamate
SODIUM IOTALAMATE (131 I)
Sodium iotalamate injection
Sodium iotalamate injection (JP17)
Sodium iothalamate
Tox21_113735
UNII-KDN276D83N
WCIMWHNSWLLELS-UHFFFAOYSA-M

US Patents and Regulatory Information for CONRAY 325

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt CONRAY 325 iothalamate sodium INJECTABLE;INJECTION 017685-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
McKinsey
Boehringer Ingelheim
Medtronic
Healthtrust
Harvard Business School
Fish and Richardson
UBS
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.